Cargando…
Characteristics of the mitochondrial and cellular uptake of MPP(+), as probed by the fluorescent mimic, 4'I-MPP(+)
The discovery that 1-methyl-4-phenylpyridinium (MPP(+)) selectively destroys dopaminergic neurons and causes Parkinson’s disease (PD) symptoms in mammals has strengthened the environmental hypothesis of PD. The current model for the dopaminergic toxicity of MPP(+) is centered on its uptake into dopa...
Autores principales: | Mapa, Mapa S. T., Le, Viet Q., Wimalasena, Kandatege |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107127/ https://www.ncbi.nlm.nih.gov/pubmed/30138351 http://dx.doi.org/10.1371/journal.pone.0197946 |
Ejemplares similares
-
The Alteration of Nasopharyngeal and Oropharyngeal Microbiota in Children with MPP and Non-MPP
por: Lu, Zhiwei, et al.
Publicado: (2017) -
2013 MPP Workshop
por: Jonker, Michael
Publicado: (2014) -
Proceedings of the 2019 MPP Workshop
por: Strachinescu, Sabina-Ioana, et al.
Publicado: (2019) -
Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+)
por: Krug, A K, et al.
Publicado: (2014) -
The inherent high vulnerability of dopaminergic neurons toward mitochondrial toxins may contribute to the etiology of Parkinson's disease
por: Wimalasena, Kandatege
Publicado: (2016)